Smith & Nephew PLC (SN)

1,084.00
-19.50(-1.77%)
  • Volume:
    4,048,711
  • Bid/Ask:
    680.00/1,111.00
  • Day's Range:
    1,077.00 - 1,093.00

SN Overview

Prev. Close
1,103.5
Day's Range
1,077-1,093
Revenue
2.95B
Open
1,077
52 wk Range
959.2-1,357.5
EPS
0.566
Volume
4,048,711
Market Cap
9.43B
Dividend (Yield)
31.31
(2.89%)
Average Volume (3m)
2,693,999
P/E Ratio
22.98
Beta
0.397
1-Year Change
-12.23%
Shares Outstanding
869,495,658
Next Earnings Date
21 Feb 2023
What is your sentiment on Smith & Nephew?
or
Market is currently closed. Voting is open during market hours.

Smith & Nephew PLC News

Smith & Nephew PLC Analysis

Smith & Nephew PLC Company Profile

Smith & Nephew PLC Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuySell
Technical IndicatorsSellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Sell
  • this is the best time to top this up. the upwards move from here will be massive and fast going past March 2023. if you are a long termer this is the last chance in my honest opinion.
    0
    • 1036
      0
      • Soon will up❤️
        0
        • Maybe nownis the time to load up a little
          1
          • Load up.
            0
            • Guuuud-bye inflation. No but seriously this a good buy to hedge against inflation.
              0
              • Good buy
                0
                • set buy target 1100
                  3
                  • just wonder why the sentiment is not bullish? reversal? don't think so
                    0
                    • bet you got wiped out hah?
                      0